LifeMD, Inc. Stock News

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11th Annual BTIG MedTech, Digital Health,

LifeMD, Inc.'s newly issued 2024 guidance indicates an impressive 38% CAGR, positioning it as an attractive investment opportunity. With a valuation priced at less than 11x forward EBITDA, LifeMD stoc

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Con

LifeMD expects a 38% increase in revenues for 2024, driven by its new telehealth operation for GLP-1 obesity drugs. Despite this, the stock is down significantly due to concerns over Eli Lilly direct

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.™  (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash div

As we head into 2024, it's common for investors to look back on 2023. Much of this year had investors in a defensive posture.

LifeMD Inc. NASDAQ: LFMD is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing with no health insurance required.

LifeMD is recording strong growth figures on the back of WorkSimpli, its SaaS offering. The company currently sports an 87.62% gross profit margin and generated positive operating cash flow for its mo

LifeMD's weight management program has attracted over 16K subscribers in two quarters, producing $24M in annual recurring revenue run rate already, and this is only the beginning. Goldman Sachs argues

LifeMD, Inc. (NASDAQ:LFMD ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Offi

LifeMD, Inc.'s share price is soaring, once again. The company's focus on GLP-1 medications integration and primary care services exemplifies its commitment to comprehensive patient care. Its consiste

LifeMD reached positive operating cash flow for the first time during its fiscal 2023 second quarter. This boosted the telehealth company's cash and equivalents position and formed an inflection point

NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced that management will be participating in two upcoming investor conferences in September.

Primarily, one reason stands above all the others regarding the incentive behind stocks with insider buying: those who are closest to a particular business would only be buying shares if they believed

LifeMD is positioned for rapid growth with the introduction of a weight management program and partnerships with Nutrisystem and Medifast. The company has seen an increase in new client signups for it